World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   2061 records for 503 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
AuthorisedYesEUCTR2016-004019-11-IT
A randomised, double-blind, parallel group, equivalence, multicentre phase III trial to compare the efficacy, safety and pharmakokinetics of HD201 to Herceptin® in patients with HER2+ early breast cancer 09/04/2018 
Not recruitingYesNCT03466411
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
08/03/2018 
Not RecruitingYesCTRI/2018/02/012091
Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of patients with Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC) 22-02-2018 
Not recruitingYesNCT03447912
Smoke-free Air Coalitions in Georgia and Armenia
21/02/2018 
AuthorisedYesEUCTR2017-004190-13-HU
A clinical trial to compare the efficacy, safety, and immunogenicity of TX05 with Herceptin® in subjects with HER2 positive early breast cancer
07/02/2018 
AuthorisedYesEUCTR2017-004294-14-LT
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn’s Disease
01/02/2018 
AuthorisedYesEUCTR2017-004295-55-LT
Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s Disease
01/02/2018 
AuthorisedYesEUCTR2017-004293-33-LT
Multicenter Study of Oral Ozanimod as Induction Therapy in patients with Moderately to Severely Active Crohn’s Disease
01/02/2018 
AuthorisedYesEUCTR2017-004294-14-HU
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn’s Disease
30/01/2018 
AuthorisedYesEUCTR2017-004295-55-HU
Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s Disease
30/01/2018 
      
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history